A detailed history of Pier Capital, LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Pier Capital, LLC holds 47,145 shares of TMDX stock, worth $2.87 Million. This represents 1.1% of its overall portfolio holdings.

Number of Shares
47,145
Previous 59,328 20.53%
Holding current value
$2.87 Million
Previous $8.94 Million 17.17%
% of portfolio
1.1%
Previous 1.39%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$135.68 - $176.11 $1.65 Million - $2.15 Million
-12,183 Reduced 20.53%
47,145 $7.4 Million
Q2 2024

Aug 07, 2024

SELL
$72.62 - $150.62 $358,089 - $742,707
-4,931 Reduced 7.67%
59,328 $8.94 Million
Q1 2024

May 02, 2024

BUY
$70.86 - $89.93 $4.55 Million - $5.78 Million
64,259 New
64,259 $4.75 Million

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $1.94B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Pier Capital, LLC Portfolio

Follow Pier Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pier Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pier Capital, LLC with notifications on news.